Skip to content
No Vape

A cost-effectiveness curve is not your chance of quitting

Read the comparator and monetary threshold on a cost-effectiveness acceptability curve before repeating its probability as a health or affordability promise.

No Vape · Updated

Stack of books on a table
Illustrative image · Laura Ohlman / Unsplash

Start with the curve’s question

A percentage beside the word cessation can look like a success rate even when the chart is economic. Find the figure title and the quantity named on the vertical axis. Then identify what the horizontal-axis threshold values purchase conceptually: an additional quitter, a quality-adjusted life-year or another defined outcome unit.

The original SCeTCH economic report concerns e-cigarettes as smoking-cessation support in homeless support centres. It describes cost-effectiveness acceptability curves for its trial-based evaluation and for a separate lifetime model. This is an example of the reported economic method; it supplies no clinical recommendation, personal quit forecast or vaping-cessation finding.

NIHR Public Health Research / original economic evaluation: Cost-effectiveness of e-cigarettes for smoking cessation at homeless support centres: SCeTCH cRCT

Retain the comparator and the threshold together

Fenwick and Byford’s original methods guide explains a CEAC as a comparative probability conditional on the data and a specified maximum acceptable cost-effectiveness ratio. A point on the curve therefore needs the alternative and threshold to retain its meaning. Removing them creates a different and unsupported claim.

In a fictional reading example, a caption gives a high probability beside a particular monetary threshold. Another summary calls it the percentage of participants who stopped vaping. Your correction restores “cost-effective compared with this alternative at this threshold” and removes the invented participant outcome. No real threshold, intervention result or numerical probability is supplied here.

Elisabeth Fenwick and Sarah Byford / British Journal of Psychiatry: A guide to cost-effectiveness acceptability curves

Keep the source of uncertainty visible

Locate whether the curve came from a trial-based resampling procedure or a model’s probabilistic analysis. These are analytical routes, not extra groups of people receiving support. A large number of resamples or model runs does not increase the observed participant count or become independent clinical replication.

The SCeTCH report separately describes bootstrap analysis over its trial period and probabilistic sensitivity analysis for a longer-term model. Preserve which curve you are reading rather than attaching the trial’s observation period to every projected quantity. A modeled horizon and an observed follow-up remain different even when they share a chart style.

NIHR Public Health Research / original economic evaluation: Cost-effectiveness of e-cigarettes for smoking cessation at homeless support centres: SCeTCH cRCT

Use the curve for a bounded reading conclusion

Write the option, comparator, outcome unit, threshold and probability statement actually shown. If the data or modeling scope is unclear, leave that part unresolved. A curve’s shape alone cannot validate its assumptions, establish coverage by an insurer or set a universal acceptable threshold for every setting.

Fenwick and Byford caution against using the curve alone to make implementation statements. Keep a personal decision equally bounded: research uncertainty about comparative value does not establish what a service costs you or which care is suitable. Obtain appropriate expertise for consequential economic or clinical interpretation. You can choose an ordinary next planning action without converting the curve into an individual outcome promise.

Elisabeth Fenwick and Sarah Byford / British Journal of Psychiatry: A guide to cost-effectiveness acceptability curves

Sources and scope

Sources inform the guidance. The worksheets and examples are No Vape editorial suggestions, not tested treatments.

  1. NIHR Public Health Research / original economic evaluation — Cost-effectiveness of e-cigarettes for smoking cessation at homeless support centres: SCeTCH cRCT
  2. Elisabeth Fenwick and Sarah Byford / British Journal of Psychiatry — A guide to cost-effectiveness acceptability curves
  3. No Vape — No Vape — app features and store links

Written with AI assistance and checked against the cited sources. No clinical review is claimed. This guide covers practical planning, not individual medical treatment. How we research and write